Diagnostic use of an antiserum made against acute lymphoid leukemia associated antigen.
Anti-ALL serum is used to distinguish common non-T, non-B ALL from Thy-ALL and "lymphoid" from myeloid blast crisis in Ph1-positive leukemia. This has prognostic and therapeutic implications.